insurance companies that cover glp-1 drugs US health plan drops coverage for weight-loss for employees How to Afford GLP-1s in
Description
Its about infrastructure, reporting, transparency, and accountability
Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain
Few studies have compared gut hormone responses between bariatric procedures
The trial was conducted in parallel in Japan, France, England, Mexico, Denmark, the USA and Germany as part of an international, randomized, double-blind study
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases.
